Is adjuvant therapy for stage II colon cancer worthwhile, and for whom? Nature clinical practice. Gastroenterology & hepatology [Nat Clin Pract Gastroenterol Hepatol] Journal article | | Title | Is adjuvant therapy for stage II colon cancer worthwhile, and for whom? | | Author(s) | Segal NH, Saltz LB | | Institution | NH Segal is a Clinical Assistant Attending Physician and Instructor in Medicine, and LB Saltz is an Attending Physician and Professor of Medicine, in the Division of Solid Tumor Oncology at the Memorial Sloan-Kettering Cancer Center, New York, NY, USA. | | Source | Nat Clin Pract Gastroenterol Hepatol 2008 Jul 1. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 18594496 |
|
|
| |
Advertise on this site.
| | |
|
